J024-0167 Screening compound: 3,3-dimethyl-1-oxo-11-phenyl-N~10~-(tetrahydro-2-furanylmethyl)-1,2,3,4,5,11-hexahydro-10H-dibenzo[b,e][1,4]diazepine-10-carboxamide

J024-0167 Screening compound: 3,3-dimethyl-1-oxo-11-phenyl-N~10~-(tetrahydro-2-furanylmethyl)-1,2,3,4,5,11-hexahydro-10H-dibenzo[b,e][1,4]diazepine-10-carboxamide
J024-0167 Screening compound: 3,3-dimethyl-1-oxo-11-phenyl-N~10~-(tetrahydro-2-furanylmethyl)-1,2,3,4,5,11-hexahydro-10H-dibenzo[b,e][1,4]diazepine-10-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J024-0167
3,3-dimethyl-1-oxo-11-phenyl-N~10~-(tetrahydro-2-furanylmethyl)-1,2,3,4,5,11-hexahydro-10H-dibenzo[b,e][1,4]diazepine-10-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J024-0167

Molecular Formula

C27H31N3O3 (C27 H31 N3 O3)

Compound Name

3,3-dimethyl-1-oxo-11-phenyl-N~10~-(tetrahydro-2-furanylmethyl)-1,2,3,4,5,11-hexahydro-10H-dibenzo[b,e][1,4]diazepine-10-carboxamide

IUPAC name

1414-dimethyl-12-oxo-N-[(oxolan-2-yl)methyl]-10-phenyl-29-diazatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)46-tetraene-9-carboxamide

SMILES

CC(C)(C1)CC(Nc(cccc2)c2N(C2c3ccccc3)C(NCC3OCCC3)=O)=C2C1=O

InChI

InChI=1S/C27H31N3O3/c1-27(2)15-21-24(23(31)16-27)25(18-9-4-3-5-10-18)30(22-13-7-6-12-20(22)29-21)26(32)28-17-19-11-8-14-33-19/h3-7,9-10,12-13,19,25,29H,8,11,14-17H2,1-2H3,(H,28,32)

InChI Key

CTZAQFNJTNQTIO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27219302

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.429

Distribution Coefficient, logD

4.407

Water Solubility, LogSw

-4.35

Polar Surface Area

57.962

Acid Dissociation Constant (pKa)

8.68

Base Dissociation Constant (pKb)

-0.91

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

40.70

J024-0167 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

New Agro Library (44492 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Agro:
  • Agro
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with J024-0167 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J024-0167?
Check Price and Availability of J024-0167, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J024-0167 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J024-0167
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J024-0167
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J024-0167 available by request